Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is J  [Clear All Filters]
2019
Kong, X., Gong, Z., Zhang, L., Sun, X., Ou, Z., Xu, B., Huang, J., Long, D., He, X., Lin, X., et al. (2019). JAK2/STAT3 signaling mediates IL-6-inhibited neurogenesis of neural stem cells through DNA demethylation/methylation.Brain Behav Immun.
Dolatabadi, S., Jonasson, E., Lindén, M., Fereydouni, B., Bäcksten, K., Nilsson, M., Martner, A., Forootan, A., Fagman, H., Landberg, G., et al. (2019). JAK-STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma.Int J Cancer.
Sawai, T., Hatta, T., and Fujita, M. (2019). Japan Significantly Relaxes Its Human-Animal Chimeric Embryo Research Regulations.Cell Stem Cell24, 513-514.
Cao, P.-L., Kumagai, N., Inoue, T., Agata, K., and Makino, T. (2019). JmjC domain-encoding genes are conserved in highly regenerative metazoans and are associated with planarian whole-body regeneration.Genome Biol Evol.
Guilak, F., Sandell, L., and Huard, J. (2019). Journal of Orthopaedic Research: Special Issue on Stem Cells.J Orthop Res.
Radulovic, V., van der Garde, M., Koide, S., Sigurdsson, V., Lang, S., Kaneko, S., and Miharada, K. (2019). Junctional Adhesion Molecule 2 Represents a Subset of Hematopoietic Stem Cells with Enhanced Potential for T Lymphopoiesis.Cell Rep27, 2826-2836.e5.
2018
Zhang, Y., Lin, C.Hua Sarah, Kaushansky, K., and Zhan, H. (2018). JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice through Thrombopoietin/MPL signaling.Stem Cells.
Forbes, L.R., Vogel, T.P., Cooper, M.A., Castro-Wagner, J., Schussler, E., Weinacht, K.G., Plant, A.S., Su, H.C., Allenspach, E.J., Slatter, M., et al. (2018). Jakinibs for the Treatment of Immunodysregulation in Patients with Gain of Function STAT1 or STAT3 Mutations.J Allergy Clin Immunol.
Celik, H., Koh, W.Kyun, Kramer, A.C., Ostrander, E.L., Mallaney, C., Fisher, D.A.C., Xiang, J., Wilson, W.C., Martens, A., Kothari, A., et al. (2018). JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells.Cancer Cell34, 741-756.e8.
2016
Langabeer, S.E., and Haslam, K. (2016). The JAK2 V617F mutation and thrombocytopenia.Hematol Oncol Stem Cell Ther.
Ojha, R., Singh, S.K., and Bhattacharyya, S. (2016). JAK-mediated Autophagy Regulates Stemness and Cell Survival in Cisplatin Resistant Bladder Cancer Cells.Biochim Biophys Acta.
Lei, X., Xu, J.-F., Chang, R.-M., Fang, F., Zuo, C.-H., and Yang, L.-Y. (2016). JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.Oncotarget.
Castagnini, F., Pellegrini, C., Perazzo, L., Vannini, F., and Buda, R. (2016). Joint sparing treatments in early ankle osteoarthritis: current procedures and future perspectives.J Exp Orthop3, 3.
Li, L., Pan, Z.-F., Huang, X., Wu, B.-W., Li, T., Kang, M.-X., Ge, R.-S., Hu, X.-Y., Zhang, Y.-H., Ge, L.-J., et al. (2016). Junctophilin 3 expresses in pancreatic beta cells and is required for glucose-stimulated insulin secretion.Cell Death Dis7, e2275.
2015
Cahill, E.F., Tobin, L.M., Carty, F., Mahon, B.P., and English, K. (2015). Jagged-1 is required for the expansion of CD4(+) CD25(+) FoxP3(+) regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells.Stem Cell Res Ther6, 19.
Debeurme, F., Lacout, C., Moratal, C., Bagley, R.G., Vainchenker, W., Adrian, F., and Villeval, J.-L. (2015). JAK2 inhibition has different therapeutic effects according to myeloproliferative neoplasm development in mice.J Cell Mol Med.
Vu, T., Austin, R., Kuhn, C.Paine, Bruedigam, C., Song, A., Guignes, S., Jacquelin, S., Ramshaw, H.S., Hill, G.R., Lopez, A.F., et al. (2015). Jak2V617F driven myeloproliferative neoplasm occurs independently of interleukin-3 receptor beta common signaling.Haematologica.
W Y Lau, W., Hannah, R., Green, A.R., and Göttgens, B. (2015). The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients.Blood125, 1679-81.
Kuo, Y.-T., Liu, Y.-L., Adebayo, B.Oluwaseun, Shih, P.-H., Lee, W.-H., Wang, L.-S., Liao, Y.-F., Hsu, W.-M., Yeh, C.-T., and Lin, C.-M. (2015). JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells.Plos One10, e0125343.
Wittmann, T., Horowitz, N., Benyamini, N., Henig, I., Zuckerman, T., Rowe, J.M., Kra-Oz, Z., M Cohen, S., Oren, I., and Avivi, I. (2015). JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications.Bone Marrow Transplant.
Rocca, A., Martelli, F., Delbue, S., Ferrante, P., Bartolozzi, D., Azzi, A., and Giannecchini, S. (2015). The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML.J Clin Virol70, 1-6.
Spencer, H.L., Slater, S.C., Rowlinson, J., Morgan, T., Culliford, L.A., Guttridge, M., Emanueli, C., Angelini, G., and Madeddu, P. (2015). A journey from basic stem cell discovery to clinical application: the case of adventitial progenitor cells.Regen Med10, 39-47.
2014
Wang, X., Ye, F., Tripodi, J., Hu, C.Siang, Qiu, J., Najfeld, V., Novak, J., Li, Y., Rampal, R., and Hoffman, R. (2014). JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis.Blood.
Li, J., Kent, D.G., Godfrey, A.L., Manning, H., Nangalia, J., Aziz, A., Chen, E., Saeb-Parsy, K., Fink, J., Sneade, R., et al. (2014). JAK2V617F-homozygosity drives a phenotypic switch between myeloproliferative neoplasms in a murine model, but is insufficient to sustain clonal expansion.Blood.
Yamamoto, S., Wu, Z., Russnes, H.G., Takagi, S., Peluffo, G., Vaske, C., Zhao, X., Vollan, H.Kristian M., Maruyama, R., Ekram, M.B., et al. (2014). JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer.Cancer Cell25, 762-777.

Pages